Identifying patients at risk for coronary heart disease: treatment implications
Author:
Open Access
- 1 December 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 19 (12) , 1776-1783
Abstract
F1Correspondence: James Shepherd, MD, Department of Patho-logical Biochemistry, University of Glasgow, Royal Infirmary, Glasgow G4 0SF, Scotland, U.K.Keywords
This publication has 36 references indexed in Scilit:
- Health Outcomes Associated With Antihypertensive Therapies Used as First-Line AgentsA Systematic Review and Meta-analysisJAMA, 1997
- HRT, Plasma Risk Factors, and Cardiovascular Disease1997
- Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: Effect on plasma lipoproteins in a two-year placebo-controlled trialAmerican Journal of Obstetrics and Gynecology, 1994
- Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemiaThe American Journal of Medicine, 1994
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993
- Influence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis, 1993
- Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart diseaseAmerican Heart Journal, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factorinDiabetologia, 1990
- Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease ? putative association via common antecedents; further evidence from the whitehall studyDiabetologia, 1988